Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Etrade now shows 9.5bill OS. They are diluting like mad. Decide your fate now. You can wait for some stores to open, but they may never happen. Just another day in the business world. Risky is risky.
An article explaining CCEL and Mexico relationship. Sorry if it was already brought up.
http://www.thestreet.com/story/10944958/1/cryo-cell-international-responds-to-announcement-of-intent-to-acquire-one-of-the-companys-global-license-affiliates.html
That is incredibly difficult in this situation, because such valuations rely on past financial performance to provide indications or trends for future performance.
Essentially, a valid sales forecast is needed. But how does any independent investor do that when SSWC is technically a new company with no operating history? It's just like any IPO valuation dilemma.
For what it's worth, with the financials current, we can still play with varying forecasts against those numbers, and give realistic targets based on those scenarios. For instance, given X sales with X growth over the next 3 years, what should the price be? It is not to say that sales and growth will be X, but what stock price should prevail if it happens.
Exactly what I was thinking. Ken is the owner of Kenergy. All he did was cut himself a 250k check. Someone please correct me.
But it is not book value, either. Ken's own estimate. That's about as good as your guess, too. Either way, not entirely a bad thing at all. If anything, this PR seems like an overdue announcement of what has always been.
Reason is, we know almost nothing about SSWC's financials. Any analysis of value prior to, and after, this PR remains completely speculative. Which also means, the details of this PR provides no additional value, actually. Everyone just keep throwing numbers out and guessing. PPS ain't going anywhere while we do that. Ken needs to whip the accountants in the ass, if that is at all applicable. Thanks.
A buyback shouldn't happen unless we are cash flow positive. Because unless I am missing something, a buyback before then means it's all bought on debt. The best you can hope for there is that the sudden price increase attracts a lot of new investors. Otherwise, that financing could have been put to much better, income generating use.
When you make a decision to spend, you want value in return. A PPS increase does NOTHING for the company if new investment that results does not offset the expenditure. It just puts short-term smiles on our faces.
It was stated that November is when the store opens, but it's probably not the case now if he's having some retarded dispute with the space. Why he would have stocks of products with no contracted space is beyond me. And the store is a questionable investment at this time anyhow, but it is what it is and let's hope it happens and is successful.
Otherwise everything is feeling bleak. I am kinda hanging onto the fact that Dr. Martin has "publicly" endorsed his deal with Ken Glynn and the bandages. All other patents and potential deals look too much like typical pink sheet hype. Not enough money and too little focus here. A million different possibilities should always be scrutinized as possible hype just for selling stock. Do ONE thing and be able to credit the company with an accomplishment and substantial, verified income. Then move on. It's times like these I wish I could review Ken's budgeting and forecasting analyses, if any exist.
AS 10 bill
OS 8 bill
RESTRICTED OF THE OS 6 bill
PPS is derived from OS. It is not 2 bill. Stop.
Yeah I'm not a fan of giant back logs. This is a small company that seems to have little focus. I want results, not a laundry list of possibilities.
Sounds good people. Thought I was content with what I have, but I'm gonna throw another grand in sometime Monday - Wednesday. CBAI very close to standing on its feet, finally.
Wake me up when the PR actually says that it's finished. This is fluff. These things have been in process for a while now. Not saying they necessarily should be done, but this PR is stating what we have assumed to be the obvious. I guess if anything, it's confirmation to calm fears, but then again, nothing concrete.
Furthermore, have you guys looked at a calendar recently? There are more filings to complete AFTER what's listed in the PR. Nowhere does it say in 2 - 3 weeks from now the company will be current. Tricky wording, you know.
That's true only you can time the market correctly. Think back a few years to the tech stock bubble. Get it?
It's a maturing sector though. Growth has only just begun and it was a long time coming. Thank Cryo-Cell for wading through it for a while.
Ok I think the jig is up. You're Bob Wilcox. Or, just stop the brown nosing. That guy has no more clue about SSWC than any of us. Not his fault, just the nature of the beast.
No, it's the current CEO, as stated by Ken Glynn. Mahoney and Knef have large, but relatively small positions.
Here is the arbitrary assignment of a Caveat Emptor rating on pink sheets:
Buyer Beware. There is a public interest concern associated with the company, which may include a spam campaign, questionable stock promotion, known investigation of fraudulent activity committed by the company or insiders, regulatory suspensions, or disruptive corporate actions. During the time it is labeled Caveat Emptor, any stock that is not in the Current Information category will also have its quotes blocked on otcmarkets.com.
This has existed for SpeechSwitch for a while now. But why should I fault Kenergy Scientific for years old faults of SpeechSwitch? But my concern is regarding what efforts are required to remove it, and where Ken Glynn should realistically be in that process. Is there a holdup? Why? Is this normal? Maybe. Good news is sooner or later he will have to say to us that the company is either current, or cannot possibly become current. Accounting delays can only last so long and he has committed to us a firm to handle the efforts.
It is not an inherently bad relationship anyway. Ken doesn't speak well of Mahoney now. But in any case, Mahoney heads up BGNN, and although the stock isn't performing spectacularly, they are doing some real business with Home Depot and QVC.
Yeah it was brought up months ago.
Glynn spun patents into other companies as I understand it. He happened to work with Mahoney, but I don't believe they started anything together. Mahoney is not supposed to have anything further to do with SSWC except that he still has a bit of stock.
Are you serious? CE is a standard label. You talk as if there was an investigation into SSWC that led to some specialized report detailing its problems. CE is CE. It is caused by a number of different reasons, not necessarily all of them at once. The only problem here is that the shit is still there. The lack of filings and reverse merge is reason enough to warrant a CE. IT's a new company, so not sure why anyone should care any more than why it is still there.
Yeah Glynn played with BGNN. IVOI led to SSWC and BGNN, so it's not as bizarre as it sounds.
Nobody is right. Just lucky.
Used to be $5. So that's good.
Anyone seeing all the recent Twitter updates? I'm thinking these are just names of the clients already numbered in the PR's. Name one at a time and draw it out. Gives the impression that it is constantly growing.
Pointing out the obvious? I believe bias is bias. Period.
We're simply talking about a stock split here. Not sure what you're getting at.
More like Repub and Repub. The only fair and balanced news is on the internet. Anyone that thinks Fox is somehow infallible is obviously biased. Sorry.
Thanks for that link. Criteria for award of the HRSA contract:
M.1 Award Criteria
This is a best value procurement. The technical proposal will receive paramount consideration in the selection of the contractor(s) for this acquisition, although estimated cost and past performance will also be considered. (Because of the Legislative restrictions, no subcontracting opportunities exist). In the event that the technical evaluation reveals that two or more offerors are approximately equal in technical ability, then the average price per unit (including all options) and past performance of an Offeror will become paramount. In any event, the Government reserves the right to make an award to the best advantage of the Government, cost and other factors considered.
The Government reserves the right to make multiple awards pursuant to this solicitation. The number of awards will be determined, in part, by the availability of funds.
Awards will be made to the most qualified offeror(s), based on the technical evaluation and the proposed price, and considering (1) the physical location of the CBB to ensure geographic dispersion of the inventory for security reasons, and (2) the Government's need to create a diversified inventory. HRSA is particularly interested in selecting banks demonstrating a superior ability to collect and bank CBU from underrepresented populations, especially African-Americans.
In any event, the Government reserves the right to make an award to the offeror(s) presenting the best value to the Government, all factors considered.
Also, just because Duke may well be the only vendor to submit a proposal, does not mean automatic award. If amendments must be made, or no offers are suitable, then CBAI can still get in on this if they haven't yet.
It may as long as the market still values either company at the current level.
Think about WHY companies split in the first place. It is to achieve a lower price point in order to attract additional investment. You can imagine that you simply double your shares, but at a lower price under two separate entities, there is high reward that they both elevate back to a currently stable half-penny. Not to mention, how much investment interest would CorCell initially generate? You know how crazy speculators run with absolutely anything new on the market. Corcell, especially, has been in business for a while.
Currently modest, yes. Don't forget it is a pioneering field (stem cell science). Banking success is and will be dependent on research success. The more common and definite stem cell cures become, the more demand there will be for stem cells to be available. It's a pretty logical conclusion to make. And ultimately this is the healthcare industry we are talking about. That is huge money. Who would say otherwise?
Well, at the moment that would make this a $500 billion market cap. Not even Apple or Walmart touches that. This is either the biggest thing of all time in the making, or that SS will need to change sometime in the next couple years.
While it may not be the patented Bioreactor, it still may be something based on expansion technology. We at least know that Corcell has this knowledge under their belt, even if this patent has nothing substantial to do with them.
Well, some small companies that can responsibly undercut will do so in order to accomplish mass market penetration. Eventually a profit is to be made, but you need to work your way into everyone's face and business first. Point being, we don't need to be the largest to be the cheapest, as long as we're not in threat of becoming insolvent. The investor presentation that seemed to accompany the PR made it clear that current funding and burn rates and acquisition projections, or whatever, are sufficient for years to come. It probably also means that they are comfortably relying on dilution, though. All good if it ever gets us anywhere.
This part makes a lot of sense to me:
"What makes CBAI.OB so special that Cord Blood China Corp and CordLife Ltd sought CBAI.OB out to give away royalties and a 10% stake in the largest stem cell factory being built in China w/o CBAI.OB dropping a dime? Know-How!"
I don't believe that, realistically speaking, Chinese Yuan is being thrown our way simply so that we can tell them how to hook up and maintain a cryogenic lab. This is all a new market, but these tools aren't so new that little old CBAI is this essential overseas. If we are doing some proprietary expansion knowledge and work sharing, then it makes a lot more sense. I hope you're right.
Never say never. Last PR was fluffy at best. The waiting game after something like that draws people away. Hopefully Monday or Tuesday a PR hits with either $$$ or SEC filings.
Who is the babe in slide 16. Rawr baby.
Government abuses this type of thing often, but there are typically rules in place to let them get away with it. I'm just wondering about details of the solicitation. Sometimes they award vendors that charge more, on a basis of better value. This may be the case here, but it'd be very interesting to hear the government's take on it if we don't get the contract. They must have a reason or this thing could end up in limbo, and we the people can't afford that typical bullshit right now.
I guess it would be really nice to know if we ever had a bid on this thing to begin with. For all we know it's completely moot.
Do you have a linky to anything per this HRSA contract? Is the period for bidding over?
Sorry guys I was wrong and no one will be getting their million shares. Shoot.
I say 11:42pm on Thursday evening and I'll buy everyone here 1,000,000 shares if I'm right.